| Kyle Lee Smith, DPT | |
|
1071 W Blue Starr Dr, Claremore, OK 74017-2868 | |
| (918) 342-3800 | |
| (918) 342-3900 |
| Full Name | Kyle Lee Smith |
|---|---|
| Gender | Male |
| Speciality | Physical Therapy |
| Experience | 8 Years |
| Location | 1071 W Blue Starr Dr, Claremore, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346690963 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 5183 (Oklahoma) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Orthopedics Of Oklahoma Pllc | 8426320912 | 69 |
News Archive
Commenting on a paper in today's (Friday 1 October) British Medical Journal on 'the hidden curriculum' in medical schools, Dr Peter Dangerfield, chair of the BMA's Board of Medical Education, said:
A team of researchers at the University of Birmingham in the United Kingdom formulated a spray that contains polysaccharides known for their mucoadhesive antiviral properties for prophylaxis against SARS-CoV-2 infection.
In a new study proteomic peptide-phage display is utilized to profile the novel SLiM-based interactions that mediate host factor interactions in 229 RNA viruses, with a special focus on SARS-CoV-2, to reveal mechanistic insights and identify drug targets.
Breast cancer patients undergoing chemotherapy often experience severe and persistent tiredness. In a recent study, a team led by researchers from the National University of Singapore (NUS) developed a novel approach to identify the onset of this common side effect and objectively follow its development.
Shire plc announced today that the U.S. Food and Drug Administration approved Vyvanse (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults, shown to significantly reduce the mean number of binge days per week.
› Verified 8 days ago
| Provider Name | Orthopaedic Center Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1639115116 PECOS PAC ID: 8123915626 Enrollment ID: O20040301000465 |
News Archive
Commenting on a paper in today's (Friday 1 October) British Medical Journal on 'the hidden curriculum' in medical schools, Dr Peter Dangerfield, chair of the BMA's Board of Medical Education, said:
A team of researchers at the University of Birmingham in the United Kingdom formulated a spray that contains polysaccharides known for their mucoadhesive antiviral properties for prophylaxis against SARS-CoV-2 infection.
In a new study proteomic peptide-phage display is utilized to profile the novel SLiM-based interactions that mediate host factor interactions in 229 RNA viruses, with a special focus on SARS-CoV-2, to reveal mechanistic insights and identify drug targets.
Breast cancer patients undergoing chemotherapy often experience severe and persistent tiredness. In a recent study, a team led by researchers from the National University of Singapore (NUS) developed a novel approach to identify the onset of this common side effect and objectively follow its development.
Shire plc announced today that the U.S. Food and Drug Administration approved Vyvanse (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults, shown to significantly reduce the mean number of binge days per week.
› Verified 8 days ago
| Provider Name | Advanced Orthopedics Of Oklahoma Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235676453 PECOS PAC ID: 8426320912 Enrollment ID: O20170817003088 |
News Archive
Commenting on a paper in today's (Friday 1 October) British Medical Journal on 'the hidden curriculum' in medical schools, Dr Peter Dangerfield, chair of the BMA's Board of Medical Education, said:
A team of researchers at the University of Birmingham in the United Kingdom formulated a spray that contains polysaccharides known for their mucoadhesive antiviral properties for prophylaxis against SARS-CoV-2 infection.
In a new study proteomic peptide-phage display is utilized to profile the novel SLiM-based interactions that mediate host factor interactions in 229 RNA viruses, with a special focus on SARS-CoV-2, to reveal mechanistic insights and identify drug targets.
Breast cancer patients undergoing chemotherapy often experience severe and persistent tiredness. In a recent study, a team led by researchers from the National University of Singapore (NUS) developed a novel approach to identify the onset of this common side effect and objectively follow its development.
Shire plc announced today that the U.S. Food and Drug Administration approved Vyvanse (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults, shown to significantly reduce the mean number of binge days per week.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kyle Lee Smith, DPT 1071 W Blue Starr Dr, Claremore, OK 74017-2868 Ph: (918) 342-3800 | Kyle Lee Smith, DPT 1071 W Blue Starr Dr, Claremore, OK 74017-2868 Ph: (918) 342-3800 |
News Archive
Commenting on a paper in today's (Friday 1 October) British Medical Journal on 'the hidden curriculum' in medical schools, Dr Peter Dangerfield, chair of the BMA's Board of Medical Education, said:
A team of researchers at the University of Birmingham in the United Kingdom formulated a spray that contains polysaccharides known for their mucoadhesive antiviral properties for prophylaxis against SARS-CoV-2 infection.
In a new study proteomic peptide-phage display is utilized to profile the novel SLiM-based interactions that mediate host factor interactions in 229 RNA viruses, with a special focus on SARS-CoV-2, to reveal mechanistic insights and identify drug targets.
Breast cancer patients undergoing chemotherapy often experience severe and persistent tiredness. In a recent study, a team led by researchers from the National University of Singapore (NUS) developed a novel approach to identify the onset of this common side effect and objectively follow its development.
Shire plc announced today that the U.S. Food and Drug Administration approved Vyvanse (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults, shown to significantly reduce the mean number of binge days per week.
› Verified 8 days ago
Reaction Physical Therapy Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1934 S Highway 66, Building C, Claremore, OK 74019 Phone: 918-283-2527 Fax: 918-283-2569 | |
Christopher Michael Beaudoin, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1071 W Blue Starr Dr, Claremore, OK 74017 Phone: 918-342-3800 Fax: 918-342-3900 | |
Mr. Brent Foster, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 224 S Brady St, Suite 109, Claremore, OK 74017 Phone: 918-923-4700 Fax: 918-923-4701 | |
Travis S Mcgill, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1071 W Blue Starr Dr, Claremore, OK 74017 Phone: 918-342-3800 Fax: 918-342-3900 | |
Dana Burrows, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1071 W Blue Starr Dr Ste 105, Claremore, OK 74017 Phone: 918-283-2992 Fax: 918-283-2952 | |
Noelle Carbone, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1071 W Blue Starr Dr Ste 105, Claremore, OK 74017 Phone: 918-283-2992 Fax: 918-927-3201 | |
Scott Michael Anderson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1934 S Highway 66, Claremore, OK 74019 Phone: 918-283-2527 Fax: 918-283-2569 |